nodes	percent_of_prediction	percent_of_DWPC	metapath
Flurazepam—CYP2E1—Dacarbazine—skin cancer	0.115	0.171	CbGbCtD
Flurazepam—CYP2A6—Fluorouracil—skin cancer	0.102	0.152	CbGbCtD
Flurazepam—ABCB1—Vismodegib—skin cancer	0.0959	0.142	CbGbCtD
Flurazepam—CYP3A4—Imiquimod—skin cancer	0.0829	0.123	CbGbCtD
Flurazepam—CYP3A4—Temozolomide—skin cancer	0.0829	0.123	CbGbCtD
Flurazepam—CYP3A4—Vismodegib—skin cancer	0.0574	0.0853	CbGbCtD
Flurazepam—ABCB1—Dactinomycin—skin cancer	0.0504	0.0748	CbGbCtD
Flurazepam—CYP3A4—Vemurafenib—skin cancer	0.0454	0.0674	CbGbCtD
Flurazepam—ABCB1—Docetaxel—skin cancer	0.026	0.0386	CbGbCtD
Flurazepam—CYP3A4—Docetaxel—skin cancer	0.0156	0.0231	CbGbCtD
Flurazepam—GABRR3—nerve—skin cancer	0.00884	0.101	CbGeAlD
Flurazepam—GABRQ—nerve—skin cancer	0.00884	0.101	CbGeAlD
Flurazepam—GABRR2—nerve—skin cancer	0.00766	0.0876	CbGeAlD
Flurazepam—Phosphatase alkaline increased—Vismodegib—skin cancer	0.00751	0.0314	CcSEcCtD
Flurazepam—GABRR1—nerve—skin cancer	0.00738	0.0843	CbGeAlD
Flurazepam—Blood alkaline phosphatase increased—Vismodegib—skin cancer	0.00626	0.0262	CcSEcCtD
Flurazepam—Aspartate aminotransferase increased—Vismodegib—skin cancer	0.00491	0.0205	CcSEcCtD
Flurazepam—Slurred speech—Fluorouracil—skin cancer	0.00488	0.0204	CcSEcCtD
Flurazepam—GABRE—hair follicle—skin cancer	0.00343	0.0392	CbGeAlD
Flurazepam—Dysgeusia—Vismodegib—skin cancer	0.00321	0.0134	CcSEcCtD
Flurazepam—Heartburn—Fluorouracil—skin cancer	0.00317	0.0133	CcSEcCtD
Flurazepam—GABRA3—neck—skin cancer	0.00311	0.0356	CbGeAlD
Flurazepam—GABRP—nipple—skin cancer	0.00304	0.0348	CbGeAlD
Flurazepam—Lethargy—Imiquimod—skin cancer	0.00293	0.0122	CcSEcCtD
Flurazepam—Arthralgia—Vismodegib—skin cancer	0.00279	0.0117	CcSEcCtD
Flurazepam—Irritability—Imiquimod—skin cancer	0.00274	0.0115	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Vismodegib—skin cancer	0.00244	0.0102	CcSEcCtD
Flurazepam—Gait disturbance—Temozolomide—skin cancer	0.00243	0.0102	CcSEcCtD
Flurazepam—Phosphatase alkaline increased—Temozolomide—skin cancer	0.00237	0.00991	CcSEcCtD
Flurazepam—Dyspepsia—Vismodegib—skin cancer	0.00236	0.00985	CcSEcCtD
Flurazepam—Decreased appetite—Vismodegib—skin cancer	0.00233	0.00973	CcSEcCtD
Flurazepam—GABRE—nipple—skin cancer	0.00232	0.0265	CbGeAlD
Flurazepam—Dysarthria—Fluorouracil—skin cancer	0.00231	0.00965	CcSEcCtD
Flurazepam—Heartburn—Docetaxel—skin cancer	0.00229	0.00957	CcSEcCtD
Flurazepam—Constipation—Vismodegib—skin cancer	0.00229	0.00957	CcSEcCtD
Flurazepam—Disorientation—Bleomycin—skin cancer	0.00228	0.00953	CcSEcCtD
Flurazepam—Gastrointestinal pain—Vismodegib—skin cancer	0.00219	0.00915	CcSEcCtD
Flurazepam—GABRR3—head—skin cancer	0.0021	0.024	CbGeAlD
Flurazepam—GABRQ—head—skin cancer	0.0021	0.024	CbGeAlD
Flurazepam—Mental disability—Temozolomide—skin cancer	0.00206	0.0086	CcSEcCtD
Flurazepam—Coma—Fluorouracil—skin cancer	0.002	0.00834	CcSEcCtD
Flurazepam—Dysgeusia—Vemurafenib—skin cancer	0.00199	0.0083	CcSEcCtD
Flurazepam—Blood alkaline phosphatase increased—Temozolomide—skin cancer	0.00198	0.00827	CcSEcCtD
Flurazepam—Lethargy—Dactinomycin—skin cancer	0.00194	0.00811	CcSEcCtD
Flurazepam—Asthenia—Vismodegib—skin cancer	0.00192	0.00803	CcSEcCtD
Flurazepam—Pruritus—Vismodegib—skin cancer	0.00189	0.00792	CcSEcCtD
Flurazepam—Euphoric mood—Fluorouracil—skin cancer	0.00188	0.00784	CcSEcCtD
Flurazepam—Flushing—Imiquimod—skin cancer	0.00184	0.0077	CcSEcCtD
Flurazepam—GABRG3—head—skin cancer	0.00184	0.021	CbGeAlD
Flurazepam—Diarrhoea—Vismodegib—skin cancer	0.00183	0.00766	CcSEcCtD
Flurazepam—GABRR2—head—skin cancer	0.00182	0.0208	CbGeAlD
Flurazepam—GABRA4—mammalian vulva—skin cancer	0.00179	0.0205	CbGeAlD
Flurazepam—Disorientation—Fluorouracil—skin cancer	0.00177	0.00741	CcSEcCtD
Flurazepam—GABRR1—head—skin cancer	0.00175	0.02	CbGeAlD
Flurazepam—Arthralgia—Vemurafenib—skin cancer	0.00173	0.00721	CcSEcCtD
Flurazepam—Aspartate aminotransferase increased—Dactinomycin—skin cancer	0.00171	0.00716	CcSEcCtD
Flurazepam—Vomiting—Vismodegib—skin cancer	0.0017	0.00712	CcSEcCtD
Flurazepam—Rash—Vismodegib—skin cancer	0.00169	0.00706	CcSEcCtD
Flurazepam—Dermatitis—Vismodegib—skin cancer	0.00169	0.00705	CcSEcCtD
Flurazepam—Anaphylactic shock—Vemurafenib—skin cancer	0.00165	0.00692	CcSEcCtD
Flurazepam—Ataxia—Temozolomide—skin cancer	0.00162	0.00676	CcSEcCtD
Flurazepam—Lethargy—Fluorouracil—skin cancer	0.00162	0.00676	CcSEcCtD
Flurazepam—Nausea—Vismodegib—skin cancer	0.00159	0.00665	CcSEcCtD
Flurazepam—Agitation—Imiquimod—skin cancer	0.00159	0.00664	CcSEcCtD
Flurazepam—Phosphatase alkaline increased—Docetaxel—skin cancer	0.00158	0.00659	CcSEcCtD
Flurazepam—Syncope—Imiquimod—skin cancer	0.00155	0.00648	CcSEcCtD
Flurazepam—Aspartate aminotransferase increased—Temozolomide—skin cancer	0.00155	0.00648	CcSEcCtD
Flurazepam—Hypotension—Vemurafenib—skin cancer	0.00155	0.00646	CcSEcCtD
Flurazepam—Palpitations—Imiquimod—skin cancer	0.00153	0.00639	CcSEcCtD
Flurazepam—GABRP—female reproductive system—skin cancer	0.00152	0.0174	CbGeAlD
Flurazepam—GABRD—head—skin cancer	0.00152	0.0174	CbGeAlD
Flurazepam—Loss of consciousness—Imiquimod—skin cancer	0.00152	0.00635	CcSEcCtD
Flurazepam—Irritability—Fluorouracil—skin cancer	0.00151	0.00632	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.00151	0.0063	CcSEcCtD
Flurazepam—Ataxia—Fluorouracil—skin cancer	0.00149	0.00623	CcSEcCtD
Flurazepam—Chest pain—Imiquimod—skin cancer	0.00147	0.00615	CcSEcCtD
Flurazepam—Arthralgia—Imiquimod—skin cancer	0.00147	0.00615	CcSEcCtD
Flurazepam—Anxiety—Imiquimod—skin cancer	0.00147	0.00613	CcSEcCtD
Flurazepam—GABRG1—head—skin cancer	0.00146	0.0167	CbGeAlD
Flurazepam—GABRA6—head—skin cancer	0.00146	0.0166	CbGeAlD
Flurazepam—Dry mouth—Imiquimod—skin cancer	0.00144	0.00602	CcSEcCtD
Flurazepam—Decreased appetite—Vemurafenib—skin cancer	0.00144	0.00601	CcSEcCtD
Flurazepam—GABRB1—head—skin cancer	0.00142	0.0162	CbGeAlD
Flurazepam—Constipation—Vemurafenib—skin cancer	0.00141	0.00591	CcSEcCtD
Flurazepam—GABRA5—head—skin cancer	0.00141	0.0161	CbGeAlD
Flurazepam—Lightheadedness—Docetaxel—skin cancer	0.00141	0.00589	CcSEcCtD
Flurazepam—GABRB3—connective tissue—skin cancer	0.0014	0.016	CbGeAlD
Flurazepam—Shock—Imiquimod—skin cancer	0.00139	0.0058	CcSEcCtD
Flurazepam—Agranulocytosis—Dactinomycin—skin cancer	0.00137	0.00572	CcSEcCtD
Flurazepam—Hyperhidrosis—Imiquimod—skin cancer	0.00136	0.0057	CcSEcCtD
Flurazepam—GABRE—mammalian vulva—skin cancer	0.00136	0.0155	CbGeAlD
Flurazepam—Anorexia—Imiquimod—skin cancer	0.00134	0.00562	CcSEcCtD
Flurazepam—Blood alkaline phosphatase increased—Docetaxel—skin cancer	0.00132	0.0055	CcSEcCtD
Flurazepam—GABRA3—head—skin cancer	0.00131	0.015	CbGeAlD
Flurazepam—Flushing—Bleomycin—skin cancer	0.00131	0.00547	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Imiquimod—skin cancer	0.00129	0.00537	CcSEcCtD
Flurazepam—GABRA4—head—skin cancer	0.00128	0.0146	CbGeAlD
Flurazepam—GABRR2—lymph node—skin cancer	0.00127	0.0145	CbGeAlD
Flurazepam—GABRP—head—skin cancer	0.00127	0.0145	CbGeAlD
Flurazepam—Dyspnoea—Imiquimod—skin cancer	0.00126	0.00526	CcSEcCtD
Flurazepam—Somnolence—Imiquimod—skin cancer	0.00125	0.00524	CcSEcCtD
Flurazepam—Dyspepsia—Imiquimod—skin cancer	0.00124	0.00519	CcSEcCtD
Flurazepam—Decreased appetite—Imiquimod—skin cancer	0.00123	0.00513	CcSEcCtD
Flurazepam—Flushing—Dactinomycin—skin cancer	0.00122	0.0051	CcSEcCtD
Flurazepam—Asthenia—Vemurafenib—skin cancer	0.00119	0.00496	CcSEcCtD
Flurazepam—Hallucination—Temozolomide—skin cancer	0.00118	0.00495	CcSEcCtD
Flurazepam—Pruritus—Vemurafenib—skin cancer	0.00117	0.00489	CcSEcCtD
Flurazepam—Lethargy—Docetaxel—skin cancer	0.00117	0.00488	CcSEcCtD
Flurazepam—Feeling abnormal—Imiquimod—skin cancer	0.00116	0.00486	CcSEcCtD
Flurazepam—GABRE—female reproductive system—skin cancer	0.00116	0.0133	CbGeAlD
Flurazepam—Gastrointestinal pain—Imiquimod—skin cancer	0.00115	0.00482	CcSEcCtD
Flurazepam—Agranulocytosis—Fluorouracil—skin cancer	0.00114	0.00476	CcSEcCtD
Flurazepam—Diarrhoea—Vemurafenib—skin cancer	0.00113	0.00473	CcSEcCtD
Flurazepam—Flushing—Temozolomide—skin cancer	0.0011	0.00462	CcSEcCtD
Flurazepam—Leukopenia—Bleomycin—skin cancer	0.0011	0.0046	CcSEcCtD
Flurazepam—Dizziness—Vemurafenib—skin cancer	0.00109	0.00457	CcSEcCtD
Flurazepam—Ataxia—Docetaxel—skin cancer	0.00108	0.0045	CcSEcCtD
Flurazepam—GABRB2—head—skin cancer	0.00107	0.0122	CbGeAlD
Flurazepam—GABRG2—head—skin cancer	0.00107	0.0122	CbGeAlD
Flurazepam—Vomiting—Vemurafenib—skin cancer	0.00105	0.0044	CcSEcCtD
Flurazepam—Chest pain—Bleomycin—skin cancer	0.00105	0.00437	CcSEcCtD
Flurazepam—Rash—Vemurafenib—skin cancer	0.00104	0.00436	CcSEcCtD
Flurazepam—Dermatitis—Vemurafenib—skin cancer	0.00104	0.00436	CcSEcCtD
Flurazepam—Headache—Vemurafenib—skin cancer	0.00104	0.00433	CcSEcCtD
Flurazepam—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.00103	0.00431	CcSEcCtD
Flurazepam—Leukopenia—Dactinomycin—skin cancer	0.00103	0.00429	CcSEcCtD
Flurazepam—Dysgeusia—Temozolomide—skin cancer	0.00101	0.00424	CcSEcCtD
Flurazepam—Asthenia—Imiquimod—skin cancer	0.00101	0.00423	CcSEcCtD
Flurazepam—Confusional state—Bleomycin—skin cancer	0.00101	0.00422	CcSEcCtD
Flurazepam—Anaphylactic shock—Bleomycin—skin cancer	0.001	0.00419	CcSEcCtD
Flurazepam—Pruritus—Imiquimod—skin cancer	0.000998	0.00417	CcSEcCtD
Flurazepam—ABCB1—blood vessel—skin cancer	0.000987	0.0113	CbGeAlD
Flurazepam—GABRB3—female reproductive system—skin cancer	0.000985	0.0113	CbGeAlD
Flurazepam—Nausea—Vemurafenib—skin cancer	0.000983	0.00411	CcSEcCtD
Flurazepam—GABRA2—head—skin cancer	0.000979	0.0112	CbGeAlD
Flurazepam—Vision blurred—Temozolomide—skin cancer	0.000976	0.00408	CcSEcCtD
Flurazepam—GABRE—head—skin cancer	0.00097	0.0111	CbGeAlD
Flurazepam—Diarrhoea—Imiquimod—skin cancer	0.000965	0.00404	CcSEcCtD
Flurazepam—Anorexia—Bleomycin—skin cancer	0.000955	0.00399	CcSEcCtD
Flurazepam—Agitation—Temozolomide—skin cancer	0.000952	0.00398	CcSEcCtD
Flurazepam—GABRA1—head—skin cancer	0.000946	0.0108	CbGeAlD
Flurazepam—Hypotension—Bleomycin—skin cancer	0.000937	0.00392	CcSEcCtD
Flurazepam—Dizziness—Imiquimod—skin cancer	0.000933	0.0039	CcSEcCtD
Flurazepam—Leukopenia—Temozolomide—skin cancer	0.000927	0.00388	CcSEcCtD
Flurazepam—Palpitations—Temozolomide—skin cancer	0.000916	0.00383	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000913	0.00382	CcSEcCtD
Flurazepam—Vision blurred—Fluorouracil—skin cancer	0.0009	0.00376	CcSEcCtD
Flurazepam—Vomiting—Imiquimod—skin cancer	0.000897	0.00375	CcSEcCtD
Flurazepam—Dyspnoea—Bleomycin—skin cancer	0.000894	0.00374	CcSEcCtD
Flurazepam—Anorexia—Dactinomycin—skin cancer	0.000891	0.00372	CcSEcCtD
Flurazepam—Rash—Imiquimod—skin cancer	0.00089	0.00372	CcSEcCtD
Flurazepam—Dermatitis—Imiquimod—skin cancer	0.000889	0.00372	CcSEcCtD
Flurazepam—Headache—Imiquimod—skin cancer	0.000884	0.00369	CcSEcCtD
Flurazepam—Arthralgia—Temozolomide—skin cancer	0.000882	0.00369	CcSEcCtD
Flurazepam—Anxiety—Temozolomide—skin cancer	0.000879	0.00367	CcSEcCtD
Flurazepam—Decreased appetite—Bleomycin—skin cancer	0.000871	0.00364	CcSEcCtD
Flurazepam—Dry mouth—Temozolomide—skin cancer	0.000863	0.00361	CcSEcCtD
Flurazepam—Leukopenia—Fluorouracil—skin cancer	0.000854	0.00357	CcSEcCtD
Flurazepam—Confusional state—Temozolomide—skin cancer	0.000853	0.00356	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000852	0.00356	CcSEcCtD
Flurazepam—Anaphylactic shock—Temozolomide—skin cancer	0.000846	0.00353	CcSEcCtD
Flurazepam—Nausea—Imiquimod—skin cancer	0.000838	0.0035	CcSEcCtD
Flurazepam—Feeling abnormal—Bleomycin—skin cancer	0.000826	0.00345	CcSEcCtD
Flurazepam—Agranulocytosis—Docetaxel—skin cancer	0.000823	0.00344	CcSEcCtD
Flurazepam—GABRB3—head—skin cancer	0.000823	0.0094	CbGeAlD
Flurazepam—Hyperhidrosis—Temozolomide—skin cancer	0.000817	0.00342	CcSEcCtD
Flurazepam—Chest pain—Fluorouracil—skin cancer	0.000813	0.0034	CcSEcCtD
Flurazepam—Decreased appetite—Dactinomycin—skin cancer	0.000813	0.0034	CcSEcCtD
Flurazepam—Anorexia—Temozolomide—skin cancer	0.000806	0.00337	CcSEcCtD
Flurazepam—Confusional state—Fluorouracil—skin cancer	0.000786	0.00328	CcSEcCtD
Flurazepam—Anaphylactic shock—Fluorouracil—skin cancer	0.000779	0.00326	CcSEcCtD
Flurazepam—Feeling abnormal—Dactinomycin—skin cancer	0.00077	0.00322	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Temozolomide—skin cancer	0.00077	0.00322	CcSEcCtD
Flurazepam—Gastrointestinal pain—Dactinomycin—skin cancer	0.000764	0.0032	CcSEcCtD
Flurazepam—Dyspnoea—Temozolomide—skin cancer	0.000754	0.00315	CcSEcCtD
Flurazepam—Somnolence—Temozolomide—skin cancer	0.000752	0.00314	CcSEcCtD
Flurazepam—Dyspepsia—Temozolomide—skin cancer	0.000744	0.00311	CcSEcCtD
Flurazepam—Anorexia—Fluorouracil—skin cancer	0.000743	0.0031	CcSEcCtD
Flurazepam—Decreased appetite—Temozolomide—skin cancer	0.000735	0.00307	CcSEcCtD
Flurazepam—Flushing—Docetaxel—skin cancer	0.000735	0.00307	CcSEcCtD
Flurazepam—Hypotension—Fluorouracil—skin cancer	0.000728	0.00304	CcSEcCtD
Flurazepam—Constipation—Temozolomide—skin cancer	0.000723	0.00302	CcSEcCtD
Flurazepam—Asthenia—Bleomycin—skin cancer	0.000719	0.00301	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.00071	0.00297	CcSEcCtD
Flurazepam—Pruritus—Bleomycin—skin cancer	0.000709	0.00296	CcSEcCtD
Flurazepam—Feeling abnormal—Temozolomide—skin cancer	0.000697	0.00291	CcSEcCtD
Flurazepam—Dyspnoea—Fluorouracil—skin cancer	0.000695	0.0029	CcSEcCtD
Flurazepam—Somnolence—Fluorouracil—skin cancer	0.000693	0.0029	CcSEcCtD
Flurazepam—Gastrointestinal pain—Temozolomide—skin cancer	0.000691	0.00289	CcSEcCtD
Flurazepam—Dyspepsia—Fluorouracil—skin cancer	0.000686	0.00287	CcSEcCtD
Flurazepam—GABRA2—lymph node—skin cancer	0.000685	0.00783	CbGeAlD
Flurazepam—GABRE—lymph node—skin cancer	0.00068	0.00777	CbGeAlD
Flurazepam—Decreased appetite—Fluorouracil—skin cancer	0.000677	0.00283	CcSEcCtD
Flurazepam—Dysgeusia—Docetaxel—skin cancer	0.000675	0.00282	CcSEcCtD
Flurazepam—Asthenia—Dactinomycin—skin cancer	0.000671	0.0028	CcSEcCtD
Flurazepam—CYP2E1—lymphoid tissue—skin cancer	0.00065	0.00742	CbGeAlD
Flurazepam—Feeling abnormal—Fluorouracil—skin cancer	0.000642	0.00268	CcSEcCtD
Flurazepam—Diarrhoea—Dactinomycin—skin cancer	0.00064	0.00267	CcSEcCtD
Flurazepam—Vomiting—Bleomycin—skin cancer	0.000637	0.00266	CcSEcCtD
Flurazepam—Rash—Bleomycin—skin cancer	0.000632	0.00264	CcSEcCtD
Flurazepam—Dermatitis—Bleomycin—skin cancer	0.000631	0.00264	CcSEcCtD
Flurazepam—CYP2E1—female reproductive system—skin cancer	0.000626	0.00716	CbGeAlD
Flurazepam—Syncope—Docetaxel—skin cancer	0.000618	0.00258	CcSEcCtD
Flurazepam—Leukopenia—Docetaxel—skin cancer	0.000617	0.00258	CcSEcCtD
Flurazepam—Palpitations—Docetaxel—skin cancer	0.000609	0.00255	CcSEcCtD
Flurazepam—Asthenia—Temozolomide—skin cancer	0.000607	0.00254	CcSEcCtD
Flurazepam—Loss of consciousness—Docetaxel—skin cancer	0.000606	0.00253	CcSEcCtD
Flurazepam—Pruritus—Temozolomide—skin cancer	0.000598	0.0025	CcSEcCtD
Flurazepam—Nausea—Bleomycin—skin cancer	0.000595	0.00249	CcSEcCtD
Flurazepam—Vomiting—Dactinomycin—skin cancer	0.000594	0.00248	CcSEcCtD
Flurazepam—Rash—Dactinomycin—skin cancer	0.000589	0.00246	CcSEcCtD
Flurazepam—Chest pain—Docetaxel—skin cancer	0.000587	0.00245	CcSEcCtD
Flurazepam—Arthralgia—Docetaxel—skin cancer	0.000587	0.00245	CcSEcCtD
Flurazepam—Diarrhoea—Temozolomide—skin cancer	0.000579	0.00242	CcSEcCtD
Flurazepam—Dry mouth—Docetaxel—skin cancer	0.000574	0.0024	CcSEcCtD
Flurazepam—Confusional state—Docetaxel—skin cancer	0.000567	0.00237	CcSEcCtD
Flurazepam—Anaphylactic shock—Docetaxel—skin cancer	0.000562	0.00235	CcSEcCtD
Flurazepam—Dizziness—Temozolomide—skin cancer	0.000559	0.00234	CcSEcCtD
Flurazepam—Nausea—Dactinomycin—skin cancer	0.000555	0.00232	CcSEcCtD
Flurazepam—Shock—Docetaxel—skin cancer	0.000553	0.00231	CcSEcCtD
Flurazepam—Pruritus—Fluorouracil—skin cancer	0.000551	0.0023	CcSEcCtD
Flurazepam—Vomiting—Temozolomide—skin cancer	0.000538	0.00225	CcSEcCtD
Flurazepam—Anorexia—Docetaxel—skin cancer	0.000536	0.00224	CcSEcCtD
Flurazepam—Rash—Temozolomide—skin cancer	0.000533	0.00223	CcSEcCtD
Flurazepam—Diarrhoea—Fluorouracil—skin cancer	0.000533	0.00223	CcSEcCtD
Flurazepam—Dermatitis—Temozolomide—skin cancer	0.000533	0.00223	CcSEcCtD
Flurazepam—Headache—Temozolomide—skin cancer	0.00053	0.00221	CcSEcCtD
Flurazepam—Hypotension—Docetaxel—skin cancer	0.000525	0.0022	CcSEcCtD
Flurazepam—CYP2E1—head—skin cancer	0.000523	0.00598	CbGeAlD
Flurazepam—Dizziness—Fluorouracil—skin cancer	0.000515	0.00215	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000512	0.00214	CcSEcCtD
Flurazepam—CYP3A4—female reproductive system—skin cancer	0.000504	0.00576	CbGeAlD
Flurazepam—Nausea—Temozolomide—skin cancer	0.000502	0.0021	CcSEcCtD
Flurazepam—Dyspnoea—Docetaxel—skin cancer	0.000501	0.0021	CcSEcCtD
Flurazepam—Somnolence—Docetaxel—skin cancer	0.0005	0.00209	CcSEcCtD
Flurazepam—Vomiting—Fluorouracil—skin cancer	0.000495	0.00207	CcSEcCtD
Flurazepam—Dyspepsia—Docetaxel—skin cancer	0.000495	0.00207	CcSEcCtD
Flurazepam—Rash—Fluorouracil—skin cancer	0.000491	0.00205	CcSEcCtD
Flurazepam—Dermatitis—Fluorouracil—skin cancer	0.000491	0.00205	CcSEcCtD
Flurazepam—Decreased appetite—Docetaxel—skin cancer	0.000489	0.00204	CcSEcCtD
Flurazepam—Headache—Fluorouracil—skin cancer	0.000488	0.00204	CcSEcCtD
Flurazepam—Constipation—Docetaxel—skin cancer	0.000481	0.00201	CcSEcCtD
Flurazepam—ABCB1—epithelium—skin cancer	0.00048	0.00549	CbGeAlD
Flurazepam—Feeling abnormal—Docetaxel—skin cancer	0.000463	0.00194	CcSEcCtD
Flurazepam—Nausea—Fluorouracil—skin cancer	0.000463	0.00193	CcSEcCtD
Flurazepam—Gastrointestinal pain—Docetaxel—skin cancer	0.00046	0.00192	CcSEcCtD
Flurazepam—ABCB1—mammalian vulva—skin cancer	0.000417	0.00476	CbGeAlD
Flurazepam—Asthenia—Docetaxel—skin cancer	0.000403	0.00169	CcSEcCtD
Flurazepam—Pruritus—Docetaxel—skin cancer	0.000398	0.00166	CcSEcCtD
Flurazepam—Diarrhoea—Docetaxel—skin cancer	0.000385	0.00161	CcSEcCtD
Flurazepam—Dizziness—Docetaxel—skin cancer	0.000372	0.00155	CcSEcCtD
Flurazepam—ABCB1—lymphoid tissue—skin cancer	0.00037	0.00423	CbGeAlD
Flurazepam—Vomiting—Docetaxel—skin cancer	0.000358	0.00149	CcSEcCtD
Flurazepam—ABCB1—female reproductive system—skin cancer	0.000357	0.00408	CbGeAlD
Flurazepam—Rash—Docetaxel—skin cancer	0.000355	0.00148	CcSEcCtD
Flurazepam—Dermatitis—Docetaxel—skin cancer	0.000354	0.00148	CcSEcCtD
Flurazepam—Headache—Docetaxel—skin cancer	0.000352	0.00147	CcSEcCtD
Flurazepam—Nausea—Docetaxel—skin cancer	0.000334	0.0014	CcSEcCtD
Flurazepam—ABCB1—head—skin cancer	0.000298	0.00341	CbGeAlD
Flurazepam—ABCB1—lymph node—skin cancer	0.000209	0.00239	CbGeAlD
